...
首页> 外文期刊>Microsurgery. >Local recombinant tissue plasminogen activator (rt-PA) thrombolytic therapy in microvascular surgery.
【24h】

Local recombinant tissue plasminogen activator (rt-PA) thrombolytic therapy in microvascular surgery.

机译:微血管外科手术中的局部重组组织纤溶酶原激活剂(rt-PA)溶栓治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

Vascular thrombosis remains a dreaded complication of any microvascular procedure, be it composite tissue transfer or replantation of amputated limbs or parts. Despite the tremendous advances in microvascular-related technologies and the accumulated surgical skills, failures caused by occlusion of anastomosed vessels remain a continuous source of frustration to all microsurgeons alike. Several anticoagulation and antiplatelet protocols have been proposed to be used in conjunction with microvascular surgery. More recently, thrombolytic drugs such as urokinase, streptokinase, and thrombolysin have been introduced, yet their systemic effect on hemostasis remains an undesirable side effect. We present our experience with local intra-arterial, intravenous, and soft-tissue injection of recombinant tissue plasminogen activator rt-PA in replantation surgery in three consecutive patients. Arterial thrombi are managed by intra-arterial rt-PA infusion with the catheter placed proximal to the arterial anastomosis. Venous thrombi are best lysed by infusing rt-PA in an engorged vein of the replanted limb. In replanted digits, direct intravenous infusion is not possible. In such situations, injection of rt-PA in the pulp soft tissues may result in successful salvage. We believe this agent also has a role in microvascular composite tissue transfer in preventing free flap failures as well as in salvaging failing flaps. Copyright 1999 Wiley-Liss, Inc.
机译:血管血栓形成仍然是任何微血管手术的可怕并发症,无论是复合组织转移还是截肢或肢体部位的再植。尽管微血管相关技术取得了巨大进步,并且外科技能不断积累,但由于吻合血管阻塞而导致的失败仍然是所有微外科医师不断感到沮丧的原因。已提出将几种抗凝和抗血小板方案与微血管外科手术结合使用。最近,已经引入了诸如尿激酶,链激酶和血栓溶素的血栓溶解药物,但是它们对止血的全身作用仍然是不良的副作用。我们介绍了我们在连续三例患者的再植手术中对重组组织纤溶酶原激活物rt-PA进行局部动脉内,静脉内和软组织注射的经验。动脉血栓通过动脉内rt-PA输注进行处理,导管放置在动脉吻合处附近。最好通过将rt-PA注入已植入肢体充血的静脉中来溶解静脉血栓。在再植入手指中,无法直接静脉输注。在这种情况下,将rt-PA注射到牙髓软组织中可能会导致成功抢救。我们认为,该药物在微血管复合组织转移中也可起到预防游离皮瓣衰竭以及挽救衰竭皮瓣的作用。版权所有1999 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号